The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine and durvalumab: a large real-life worldwide population

Journal:

Journal of the National Cancer Institute

Published:

2025-07-03

DOI:

10.1093/jnci/djaf155

Affiliations:

56

Authors:

71

Go to article

Institutions	Authors	Share
University Polyclinic, Campus Bio-Medico University, Italy	4.352564	0.06
Vita-Salute San Raffaele University (UniSR), Italy	4.000000	0.06
IRCCS Istituto Oncologico Veneto (IOV), Italy	2.833333	0.04
Careggi University Hospital (AOUC), UNIFI, Italy	2.705128	0.04
National Cancer Center Hospital East, Japan	2.352564	0.03
University Hospitals Leuven (UZ Leuven), Belgium	2.352564	0.03
Seoul National University Bundang Hospital (SNUBH), South Korea	2.090659	0.03
Mayo Clinic, United States of America (USA)	2.090659	0.03
IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Italy	2.090659	0.03
Santa Maria delle Croci Hospital, Italy	2.090659	0.03
University Hospital Frankfurt, GU, Germany	2.090659	0.03
IRCCS National Cancer Institute (INT) Milan, Italy	2.090659	0.03
University of Glasgow, United Kingdom (UK)	2.090659	0.03
University of Naples Federico II (UNINA), Italy	2.019231	0.03
Hannover Medical School (MHH), Germany	1.352564	0.02
University Hospital of Pisa, UNIPI, Italy	1.333333	0.02
Ulm University Medical Center, Germany	1.181319	0.02
IRCCS Humanitas Research Hospital, Italy	1.090659	0.02
Azienda Ospedaliero Universitaria Ospedali Riuniti - Foggia, Italy	1.090659	0.02
University of Foggia (UNIFG), Italy	1.090659	0.02
CHA Bundang Medical Center, South Korea	1.090659	0.02
IRCCS Azienda Ospedaliera Universitaria San Martino, Italy	1.090659	0.02
Vall d'Hebron University Hospital (HUVH), ICS, Spain	1.090659	0.02
Ospedale Cardinale Giovanni Panico, Italy	1.090659	0.02
Asan Medical Center (AMC), South Korea	1.090659	0.02
United Hospitals of Ancona, Italy	1.090659	0.02
Ospedale del Mare, Italy	1.090659	0.02
Azienda Universitario Ospedaliera di Cagliari, Italy	1.090659	0.02
Medical University of Vienna (MUW), Austria	1.090659	0.02
IRCCS Istituto Nazionale Tumori IRCCS-Fondazione G. Pascale, Italy	1.090659	0.02
Belcolle Hospital, Italy	1.090659	0.02
Haeundae Paik Hospital, Inje University, South Korea	1.090659	0.02
Fondazione Poliambulanza Istituto Ospedaliero, Italy	1.090659	0.02
Polyclinic Umberto I Hospital, Italy	1.090659	0.02
Sapienza University of Rome, Italy	1.090659	0.02
Azienda Ospedaliera di Desenzano del Garda (ASST Garda), Italy	1.090659	0.02
University Hospitals Parma Medical Center, Italy	1.090659	0.02
IRCCS Casa Sollievo della Sofferenza Hospital, Italy	1.090659	0.02
Ospedale Vito Fazzi, Italy	1.090659	0.02
Hospital Santa Maria, Portugal	1.090659	0.02
Portuguese Oncology Institute (IPO), Portugal	1.090659	0.02
San Luigi University Hospital, Italy	1.090659	0.02
IRCCS Policlinico San Matteo, Italy	0.590659	0.01
University of Pavia (UNIPV), Italy	0.590659	0.01
Spanish Society of Medical Oncology (SEOM), Spain	0.590659	0.01
Hospital Universitario 12 de Octubre, Spain	0.590659	0.01
Prince of Wales Hospital (PWH), China	0.590659	0.01
State Key Laboratory of Translational Oncology, CUHK, China	0.590659	0.01
University of Padova (UNIPD), Italy	0.590659	0.01
University of Pisa (UNIPI), Italy	0.352564	0.00
Humanitas University, Italy	0.090659	0.00
Princess Margaret Cancer Centre, U of T, Canada	0.019231	0.00
Toronto General Hospital (TGH), U of T, Canada	0.019231	0.00

Interested in Oncology and Carcinogenesis?